These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7886020)

  • 1. Human placenta: a direct target for cocaine action.
    Ganapathy V; Leibach FH
    Placenta; 1994 Dec; 15(8):785-95. PubMed ID: 7886020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human placental monoamine transporters as targets for amphetamines.
    Ramamoorthy JD; Ramamoorthy S; Leibach FH; Ganapathy V
    Am J Obstet Gynecol; 1995 Dec; 173(6):1782-7. PubMed ID: 8610762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human placenta as a target organ for cocaine action: interaction of cocaine with the placental serotonin transporter.
    Prasad PD; Leibach FH; Mahesh VB; Ganapathy V
    Placenta; 1994 Apr; 15(3):267-78. PubMed ID: 8066050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine, reward, movement and monoamine transporters.
    Uhl GR; Hall FS; Sora I
    Mol Psychiatry; 2002; 7(1):21-6. PubMed ID: 11803442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine up-regulates norepinephrine transporter binding in the rat placenta.
    Shearman LP; Meyer JS
    Eur J Pharmacol; 1999 Dec; 386(1):1-6. PubMed ID: 10611457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast.
    Ramamoorthy S; Prasad PD; Kulanthaivel P; Leibach FH; Blakely RD; Ganapathy V
    Biochemistry; 1993 Feb; 32(5):1346-53. PubMed ID: 8448143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
    Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
    Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prenatal cocaine exposure on serotonin and norepinephrine transporter density in the rat brain.
    McReynolds AM; Meyer JS
    Ann N Y Acad Sci; 1998 Jun; 846():412-4. PubMed ID: 9668438
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of human placenta in studies of monoamine transporters.
    Ganapathy V; Prasad PD; Leibach FH
    Methods Enzymol; 1998; 296():278-90. PubMed ID: 9779455
    [No Abstract]   [Full Text] [Related]  

  • 10. The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.
    Pörzgen P; Park SK; Hirsh J; Sonders MS; Amara SG
    Mol Pharmacol; 2001 Jan; 59(1):83-95. PubMed ID: 11125028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
    Shimazu S; Tsunekawa H; Yoneda F; Katsuki H; Akaike A; Janowsky A
    Eur J Pharmacol; 2003 Dec; 482(1-3):9-16. PubMed ID: 14659999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs of abuse and human placenta.
    Ganapathy V
    Life Sci; 2011 May; 88(21-22):926-30. PubMed ID: 20932493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lanthanides inhibit the human noradrenaline, 5-hydroxytryptamine and dopamine transporters.
    Bryan-Lluka LJ; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):699-706. PubMed ID: 9205953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues.
    Husbands SM; Izenwasser S; Kopajtic T; Bowen WD; Vilner BJ; Katz JL; Newman AH
    J Med Chem; 1999 Oct; 42(21):4446-55. PubMed ID: 10543888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-substituted-6-amino-5-phenylbicyclo[2.2.2]octanes.
    Javanmard S; Deutsch HM; Collard DM; Kuhar MJ; Schweri MM
    J Med Chem; 1999 Nov; 42(23):4836-43. PubMed ID: 10579846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration.
    Burchett SA; Bannon MJ
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):95-102. PubMed ID: 9387868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
    Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
    Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental norepinephrine transporter development in the ovine fetus.
    Bzoskie I; Blount I; Kashiwai K; Humme J; Padbury JF
    Placenta; 1997 Jan; 18(1):65-70. PubMed ID: 9032811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics.
    Sato T; Kitayama S; Mitsuhata C; Ikeda T; Morita K; Dohi T
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):214-20. PubMed ID: 10685879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine.
    Tanda G; Pontieri FE; Frau R; Di Chiara G
    Eur J Neurosci; 1997 Oct; 9(10):2077-85. PubMed ID: 9421168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.